FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Pfost Dale R		 2. Date of Event Requiring Statement (MM/DD/YYYY)
10/25/2021 

 3. Issuer Name and Ticker or Trading Symbol

Chemomab Therapeutics Ltd. [CMMB]
(Last)        (First)        (Middle)

1316 JEFFERSON AVE		 4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                          _____ 10% Owner
___X___ Officer (give title below)        _____ Other (specify below)
Chief Executive Officer /
(Street)

NEW ORLEANS, LA 70115      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		2. Amount of Securities Beneficially Owned
(Instr. 4)		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)		2. Date Exercisable and Expiration Date
(MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Option to Purchase American Depositary Shares (1) (2)10/25/2031 American Depositary Shares (1)459353 $10.05 D  
Explanation of Responses:
(1) Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
(2) The options vest and become exercisable over a period of four (4) years with one quarter (1/4) of the options vesting on October 25, 2022 -- the first anniversary of the grant date -- and the remainder in equal amounts over the ensuing 36 monthly periods, subject to the Reporting Person's continued service.
Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Pfost Dale R
1316 JEFFERSON AVE
NEW ORLEANS, LA 70115		X
Chief Executive Officer
Signatures
/s/ Matthew Rudolph, Attorney-in-Fact for Dale R. Pfost11/4/2021
**Signature of Reporting PersonDate
Anchiano Therapeutics (NASDAQ:ANCN)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Anchiano Therapeutics Charts.
Anchiano Therapeutics (NASDAQ:ANCN)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Anchiano Therapeutics Charts.